Literature DB >> 1445978

Capsular types of Streptococcus pneumoniae isolated from blood and CSF during 1982-1987.

S V Nielsen1, J Henrichsen.   

Abstract

Knowledge about the type distribution of Streptococcus pneumoniae is fundamental to ensure an effective formulation of pneumococcal vaccine, especially with the possibility of producing a polysaccharide-protein-conjugated vaccine for the prevention of invasive disease in children. During the 6-year period 1982-1987, we received and typed 10,298 isolates from patients with invasive pneumococcal disease: 7,812 (76%) from blood and 2,486 (24%) from CSF. Of all isolates, 81% were recovered from individuals in Europe and 23% were from children. In order of frequency, S. pneumoniae types 6A + 6B, 14, 18C, 19F, 1, 7F, 23F, 19A, 4, and 5 were most commonly isolated from children, and types 3, 1, 14, 7F, 4, 6A + 6B, 8, 23F, 9V, and 19F, from adults. The pneumococcal types in the currently available 23-valent vaccine represented 87% of all isolates in this study, but the proportion of vaccine types varied somewhat with age and source. In all pneumococcal groups included in the vaccine, the vaccine types represented > 80% of the isolates, except in groups 6, 15, and 18.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1445978     DOI: 10.1093/clind/15.5.794

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  17 in total

1.  Genetic relatedness within serotypes of penicillin-susceptible Streptococcus pneumoniae isolates.

Authors:  K Overweg; D Bogaert; M Sluijter; J Yother; J Dankert; R de Groot; P W Hermans
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

2.  Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.

Authors:  C Neeleman; S P Geelen; P C Aerts; M R Daha; T E Mollnes; J J Roord; G Posthuma; H van Dijk; A Fleer
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Application of capsular sequence typing (CST) to serotype non-viable Streptococcus pneumoniae isolates from an old collection.

Authors:  G Errico; C Lucarelli; F D'Ambrosio; M Del Grosso; L Ingrosso; A Pantosti; R Camilli
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-08-31       Impact factor: 3.267

4.  Invasive Streptococcus pneumoniae infections: serotype distribution and antimicrobial resistance in Canada, 1992-1995.

Authors:  M Lovgren; J S Spika; J A Talbot
Journal:  CMAJ       Date:  1998-02-10       Impact factor: 8.262

5.  Molecular epidemiological characteristics of pneumococcal meningitis in children.

Authors:  R F Kornelisse; M Sluijter; L Spanjaard; P W Hermans; R de Groot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-08       Impact factor: 3.267

6.  Molecular analysis by pulsed-field gel electrophoresis of penicillin-resistant Streptococcus pneumoniae from Toulouse, France.

Authors:  J C Lefèvre; M A Bertrand; G Faucon
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-06       Impact factor: 3.267

7.  Six newly recognized types of Streptococcus pneumoniae.

Authors:  J Henrichsen
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

8.  Dangers of oral fluoroquinolone treatment in community acquired upper respiratory tract infections.

Authors:  R J Körner; D S Reeves; A P MacGowan
Journal:  BMJ       Date:  1994-01-15

9.  Immunization of mice with pneumolysin toxoid confers a significant degree of protection against at least nine serotypes of Streptococcus pneumoniae.

Authors:  J E Alexander; R A Lock; C C Peeters; J T Poolman; P W Andrew; T J Mitchell; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

Review 10.  What can children gain from pneumococcal conjugate vaccines?

Authors:  Heikki Peltola; Robert Booy; Heinz-Josef Schmitt
Journal:  Eur J Pediatr       Date:  2004-06-10       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.